We proceeded to test the ability of BiRN to predict the therapeutic efficacy of other nanomedicines. PEGylated doxorubicin liposome (Doxil) was chosen as model nanomedicine for further experiments. We first performed the correlation analysis of intracellular BiRN nanoprobes and Doxil. After sequential inj...